Evidence map›Paper›PMID 24798639›Full record

ArticleHepatology (Baltimore, Md.)2014

Expansion of prominin-1-expressing cells in association with fibrosis of biliary atresia.

Nirmala Mavila, David James, Pranavkumar Shivakumar, Marie V Nguyen, Sarah Utley, Katrina Mak, Allison Wu, Shengmei Zhou, Larry Wang, Christopher Vendyres and 3 more

Open access · greenAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Liver fibrosis in biliary atresia.World journal of pediatrics : WJP · 2019
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Nirmala MavilaDevelopmental Biology, Regenerative Medicine and Stem Cell Program, The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA.
David James
Pranavkumar Shivakumar
Marie V Nguyen
Sarah Utley
Katrina Mak
Allison Wu
Shengmei Zhou
Larry Wang
Christopher Vendyres
Megan Groff
Kinji Asahina
Kasper S Wang
Boston Children's Hospital · USChildren's Hospital of Los Angeles · USCincinnati Children's Hospital Medical Center · USUniversity of Southern California · US

Funding

Limited Competition for the Continuation of the Childhood Liver Disease Research Network (ChilLDRen) Clinical Centers.U01DK084538 · NIDDK · CHILDREN'S HOSPITAL OF LOS ANGELES · PI KOHLI, ROHIT · 2009 to 2023
$4.8M
Contribution of the mesothelium to alcohol-induced liver fibrosisR01AA020753 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ASAHINA, KINJI · 2011 to 2015
$1.7M
Role of FGF10 in liver organogenesis and alcohol-impaired regenerationK08AA016290 · NIAAA · CHILDREN'S HOSPITAL OF LOS ANGELES · PI WANG, KASPER SAONUN · 2006 to 2010
$836k
NIAAA NIH HHS K08 AA016290NIAAA NIH HHS R01 AA020753NIDDK NIH HHS U01 DK084538NIDDK NIH HHS U01 DK084538-01PHS HHS K08 AAA01690
6 · The paper itself

Abstract

unlabelledBiliary atresia (BA), the most common cause of end-stage liver disease and the leading indication for pediatric liver transplantation, is associated with intrahepatic ductular reactions within regions of rapidly expanding periportal biliary fibrosis. Whereas the extent of such biliary fibrosis is a negative predictor of long-term transplant-free survival, the cellular phenotypes involved in the fibrosis are not well established. Using a rhesus rotavirus-induced mouse model of BA, we demonstrate significant expansion of a cell population expressing the putative stem/progenitor cell marker, PROMININ-1 (PROM1), adjacent to ductular reactions within regions of periportal fibrosis. PROM1positive (pos) cells express Collagen-1α1. Subsets of PROM1pos cells coexpress progenitor cell marker CD49f, epithelial marker E-CADHERIN, biliary marker CYTOKERATIN-19, and mesenchymal markers VIMENTIN and alpha-SMOOTH MUSCLE ACTIN (αSMA). Expansion of the PROM1pos cell population is associated with activation of Fibroblast Growth Factor (FGF) and Transforming Growth Factor-beta (TGFβ) signaling. In vitro cotreatment of PROM1-expressing Mat1a-/- hepatic progenitor cells with recombinant human FGF10 and TGFβ1 promotes morphologic transformation toward a myofibroblastic cell phenotype with increased expression of myofibroblastic genes Collagen-1α1, Fibronectin, and α-Sma. Infants with BA demonstrate similar expansion of periportal PROM1pos cells with activated Mothers Against Decapentaplegic Homolog 3 (SMAD3) signaling in association with increased hepatic expression of FGF10, FGFR1, and FGFR2 as well as mesenchymal genes SLUG and SNAIL. Infants with perinatal subtype of BA have higher tissue levels of PROM1 expression than those with embryonic subtype.

conclusionExpansion of collagen-producing PROM1pos cells within regions of periportal fibrosis is associated with activated FGF and TGFβ pathways in both experimental and human BA. PROM1pos cells may therefore play an important role in the biliary fibrosis of BA.

Indexed as

AC133 AntigenAnimalsAntigens, CDbeta CateninBiliary AtresiaDisease Models, AnimalFemaleFibroblast Growth FactorsGlycoproteinsHumansLiver CirrhosisMaleMiceMice, Inbred BALB CMice, Inbred C57BLPeptidesAC133 AntigenAntigens, CDbeta CateninFibroblast Growth FactorsGlycoproteinsPeptidesPROM1 protein, humanProm1 protein, mouseProto-Oncogene Proteins c-aktTransforming Growth Factor beta

Identifiers

PMID24798639
PMCPMC4146699
OpenAlexW2131793910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.